A severe case of rhabdomyolysis after Moderna mRNA anti‐COVID‐19 vaccine with a literature review

Maria Sheka; Yann Coattrenec; Kuntheavy Ing Lorenzini; Mathieu Nendaz

doi:10.1002/ccr3.7184

Clinical Case Reports (May 2023)

A severe case of rhabdomyolysis after Moderna mRNA anti‐COVID‐19 vaccine with a literature review

Maria Sheka,
Yann Coattrenec,
Kuntheavy Ing Lorenzini,
Mathieu Nendaz

Affiliations

Maria Sheka: Department of Medicine, Division of General Internal Medicine Geneva University Hospitals Geneva Switzerland
Yann Coattrenec: Department of Medicine, Division of Immunology and Allergology Geneva University Hospitals Geneva Switzerland
Kuntheavy Ing Lorenzini: Department of Medicine Geneva University Hospitals and Faculty of Medicine, University of Geneva Geneva Switzerland
Mathieu Nendaz: Department of Medicine, Division of General Internal Medicine Geneva University Hospitals Geneva Switzerland

DOI: https://doi.org/10.1002/ccr3.7184
Journal volume & issue: Vol. 11, no. 5
pp. n/a – n/a

Abstract

Read online

Abstract The identification of rhabdomyolysis as a potential fatal adverse reaction to recent COVID‐19 vaccines is essential. As the symptoms of rhabdomyolysis are not specific, the threshold to actively search for this complication should be low.

Published in Clinical Case Reports

ISSN: 2050-0904 (Online)
Publisher: Wiley
Country of publisher: United Kingdom
LCC subjects: Medicine: Medicine (General)
Website: https://onlinelibrary.wiley.com/journal/20500904

About the journal

Abstract

Keywords